Cetrotide Kit
Product Images NDC 44087-1225

13 FDA label images from Emd Serono, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Cetrotide (NDC 44087-1225). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cetrotide 01)

Chemical Structure (Cetrotide 01)
Chemical structure diagram of cetrorelix acetate, the active ingredient in Cetrotide. The diagram shows the molecular arrangement including atoms and bonds relevant to cetrorelix acetate.*
FDA Label Image

Figure (Cetrotide 02)

Figure (Cetrotide 02)
Illustration depicting a hand holding a vial or syringe, likely demonstrating preparation or administration technique for Cetrotide (cetrorelix acetate) subcutaneous injection kit by EMD Serono, Inc.*
FDA Label Image

Figure (Cetrotide 03)

Figure (Cetrotide 03)
Cetrotide kit including a small vial, a syringe, and two needles displayed on a flat surface. The kit is intended for subcutaneous administration and labeled by EMD Serono, Inc. The vial likely contains cetrorelix acetate, consistent with the product type as a human prescription drug.*
FDA Label Image

Figure (Cetrotide 04)

Figure (Cetrotide 04)
An instructional illustration showing two steps for preparing the Cetrotide kit. The first step depicts a sealed vial with an arrow indicating removal of the cap. The second step shows hands removing the vial's rubber stopper, indicating preparation steps before use of the subcutaneous kit by EMD Serono, Inc.*
FDA Label Image

Figure (Cetrotide 05)

Figure (Cetrotide 05)
An instructional illustration showing a syringe and a vial or container cap being removed or prepared for subcutaneous injection. The image provides a visual guide for handling the syringe and vial cap typically included in a drug administration kit.*
FDA Label Image

Figure (Cetrotide 06)

Figure (Cetrotide 06)
An instructional illustration showing a syringe drawing liquid from a vial, indicating preparation or administration steps for the medication. No text is visible.*
FDA Label Image

Figure (Cetrotide 07)

Figure (Cetrotide 07)
An instructional illustration showing a hand holding a syringe with liquid being drawn from a vial, demonstrating the preparation of an injection. This image is typical for subcutaneous drug administration guides such as for Cetrotide (cetrorelix acetate) kits.*
FDA Label Image

Figure (Cetrotide 08)

Figure (Cetrotide 08)
An instructional illustration showing the preparation of an injection using a vial and a syringe with a needle, indicating the direction to draw medication from the vial into the syringe. This diagram is associated with Cetrotide, cetrorelix acetate subcutaneous injection kit by EMD Serono, Inc.*
FDA Label Image

Figure (Cetrotide 09)

Figure (Cetrotide 09)
An instructional diagram showing the steps to use a syringe, likely indicating proper needle positioning or removal technique, related to administering Cetrotide (cetrorelix acetate) subcutaneously from a kit.*
FDA Label Image

Figure (Cetrotide 10)

Figure (Cetrotide 10)
An illustration showing a syringe used for subcutaneous injection, likely indicating the administration method of Cetrotide (cetrorelix acetate) subcutaneous kit by EMD Serono, Inc.*
FDA Label Image

Figure (Cetrotide 11)

Figure (Cetrotide 11)
Instructional illustration likely showing the preparation and subcutaneous injection of Cetrotide. The left panel depicts a hand raising the abdomen area, while the right panel shows a hand administering an injection into the skin fold. This diagram is typical in subcutaneous injection guides for Cetrotide kits by EMD Serono, Inc.*
FDA Label Image

Figure (Cetrotide 12)

Figure (Cetrotide 12)
An instructional illustration showing the disposal process of a medical item into a biohazard sharps container. The image depicts a hand placing a used syringe or similar object into the container marked 'BIOHAZARD'.*
FDA Label Image

Principal Display Panel (Kit Carton)

Principal Display Panel (Kit Carton)
Cetrotide 0.25 mg kit packaging label, containing cetrorelix acetate for injection. The label states it is sterile and for subcutaneous use only, prescription only, and must be stored refrigerated at 2-8°C (36-46°F). The kit includes one vial with lyophilized powder for reconstitution, one pre-filled syringe with diluent, one 20-gauge needle, and one 27-gauge needle. The labeler is EMD Serono, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.